Exhibit
99.1
SXC
HEALTH SOLUTIONS ANNOUNCES RE-ALIGNMENT PLAN TO OPTIMIZE COSTS AND DRIVE GROWTH;
UPDATES 2007 OUTLOOK
-
Program cost savings of approximately $3.0 million annually -
Lisle,
Illinois, October 1, 2007, SXC Health Solutions, Inc. (“SXC” or the
“Company”) (NASDAQ: SXCI, TSX: SXC), a leading provider of pharmacy benefits
management (“PBM”) services and healthcare IT solutions to the healthcare
benefits management industry, today unveiled a re-alignment plan to optimize
its
cost structure and enhance its growth prospects. This program is expected to
generate annual cost savings of approximately $3.0 million, a portion of which
will be re-deployed to support the fastest growing segments of the Company’s
business.
To
generate cost savings, the Company has reduced its workforce by approximately
7%. These reductions were focused on the provider and administrative segments
of
the business. Most of the reductions took place at the Company’s Lisle, Illinois
location. SXC now employs 425 people.
“Having
completed a thorough review of the business, we believe this is the right time
to reduce costs in certain areas of our operations in order to focus our
resources on our PBM services and transaction processing business segments,
the
most rapidly growing segments of the Company,” said Gordon S. Glenn, Chairman
and CEO of SXC. “We believe that these re-alignment measures will allow us to
deliver on our full potential and achieve our long-term revenue growth
objectives and margin expansion.”
SXC
will incur one-time severance costs of approximately $0.8 million, which will
be
reflected in the Company’s third quarter fiscal 2007 financial results. The
Company expects that this charge will be partially offset by related cost
savings in the fourth quarter of fiscal 2007. However, starting in the fourth
quarter and into fiscal 2008, SXC intends to hire new personnel in sales and
to
support the areas of the business with the most promising growth opportunities,
effectively re-investing a portion of the savings from the staff reductions
back
into the business.
In
addition, the Company continues to experience higher then expected legal and
professional fees related to delayed and protested contracts as well as
additional receivable reserves, resulting in an additional charge in the third
quarter of approximately $0.8 million. This charge and the severance cost are
expected to have a combined impact of approximately ($0.05) on earnings per
share (“EPS”) in 2007.
2007
Guidance
SXC
is
lowering its 2007 revenue guidance in two areas: 1) a reduction of $2.5-$3.0
million of system sales revenue due to continued delays in the signing of
certain contracts as well as slower than expected retail pharmacy sales and
implementations; and 2) the deferral of $0.4-$0.8 million in transaction
processing revenue from certain informedRx contracts relative to service level
objectives which may not be met in 2007. The Company believes that it will
be
successful signing a majority these delayed agreements and recognizing a
significant portion of the deferred revenue in 2008.
SXC’s
guidance for fiscal 2007 is now the following: revenue of $92-$93 million;
adjusted EBITDA of $19 - 20 million; Pre-tax net income of $15.5-$16.5 million;
and EPS of $0.51-$0.55. Severance costs of $0.8 million are included in the
revised EPS forecast.
Mr.
Glenn added: “Although we are very dissatisfied to be revising our outlook for
this year, we expect to be successful with our delayed contract signings and
to
rebound in 2008. We remain confident that we have the right strategy and
technology platform to continue to grow our market share and that the actions
we
are taking to re-allocate resources within the organization are essential steps
to enhance our operational efficiency and to best position the Company to resume
its historical growth trend.”
The
Company will provide additional updates on its re-alignment plan during its
third quarter 2007 conference call on November 8, 2007.
About
SXC Health Solutions
SXC
Health Solutions, Inc. (SXC) is a leading provider of pharmacy benefits
management (PBM) services and healthcare IT solutions to the healthcare benefits
management industry. The Company's product offerings and solutions combine
a
wide range of software applications, application service provider (ASP)
processing services and professional services, designed for many of the largest
organizations in the pharmaceutical supply chain, such as Federal, provincial,
and, state and local governments, pharmacy benefit managers, managed care
organizations, retail pharmacy chains and other healthcare intermediaries.
SXC
is based in Lisle, Illinois with locations in; Scottsdale, Arizona; Warminster,
Pennsylvania; Alpharetta, Georgia; Milton, Ontario and Victoria, British
Columbia. For more information please visit www.sxc.com.
Forward-Looking
Statements
Certain
statements included herein, including those that express management's
expectations or estimates of our future performance, constitute "forward-looking
statements" within the meaning of applicable securities
laws. Forward-looking statements are necessarily based upon a
number of estimates and assumptions that, while considered reasonable by
management at this time, are inherently subject to significant business,
economic and competitive uncertainties and contingencies. We
caution that such forward-looking statements involve known and unknown risks,
uncertainties and other risks that may cause our actual financial results,
performance, or achievements to be materially different from our estimated
future results, performance or achievements expressed or implied by those
forward-looking statements. Numerous factors could cause actual
results to differ materially from those in the forward-looking statements,
including without limitation, our ability to achieve increased market
acceptance for our product offerings and penetrate new markets; consolidation
in
the healthcare industry; the existence of undetected errors or similar problems
in our software products; our ability to identify and complete acquisitions,
manage our growth and integrate acquisitions; our ability to compete
successfully; potential liability for the use of incorrect or incomplete data;
the length of the sales cycle for our healthcare software solutions;
interruption of our operations due to outside sources; our dependence on key
customers; maintaining our intellectual property rights and litigation involving
intellectual property rights; our ability to obtain, use or successfully
integrate third-party licensed technology; compliance with existing laws,
regulations and industry initiatives and future change in laws or regulations
in
the healthcare industry; breach of our security by third parties; our dependence
on the expertise of our key personnel; our access to sufficient capital to
fund
our future requirements; and potential write-offs of goodwill or other
intangible assets.This list is not exhaustive of the factors that may
affect any of our forward-looking statements. Investors are cautioned
not to put undue reliance on forward-looking statements. All
subsequent written and oral forward-looking statements attributable to SXC
or
persons acting on our behalf are expressly qualified in their entirety by this
notice. We disclaim any intent or obligation to update publicly these
forward-looking statements, whether as a result of new information, future
events or otherwise. Risks and uncertainties about our business
are more fully discussed in our Annual Information Form.
Certain
of the assumptions made in preparing forward-looking information and
management’s expectations include: maintenance of our existing customers and
contracts, our ability to market our products successfully to anticipated
customers, the impact of increasing competition, the growth of prescription
drug
utilization rates at predicted levels, the retention of our key personnel,
our
customers continuing to process transactions at historical levels, that our
systems will not be interrupted for any significant period of time, that our
products will perform free of major errors, our ability to obtain financing
on
acceptable terms and that there will be no significant changes in the regulation
of our business.
For
more information, please contact:
|
Jeff
Park
|
Dave
Mason
|
Susan
Noonan
|
|
Chief
Financial Officer
|
Investor
Relations
|
Investor
Relations - U.S.
|
|
SXC
Health Solutions, Inc.
|
The
Equicom Group Inc.
|
The
SAN Group, LLC
|
|
Tel:
(630) 577-3206
|
416-815-0700
ext. 237
|
(212)
966-3650
|
|
investors@sxc.com
|
dmason@equicomgroup.com
|
susan@sanoonan.com
|